Wan Yee Lau
- Hepatology top 0.02%
- Surgery top 0.1%
- Epidemiology top 0.2%
- Oncology top 0.2%
- Pulmonary and Respiratory Medicine top 0.2%
- Co-authors
- Eric C. H. LaiPaul B.S. LaiRong GuoMin-Shan ChenMengchao WuYa-Qi ZhangXiao-Jun LinKa Lau Leung
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (254 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (141 papers)Liver Disease Diagnosis and Treatment (118 papers)
- Cited by
- HepatologyOncologySurgery
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Wan Yee Lau
427 papers receiving 18.7k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Hepatology 10.8k
- Surgery 8.0k
- Epidemiology 5.7k
- Oncology 5.4k
- Pulmonary and Respiratory Medicine 4.3k
Countries citing papers authored by Wan Yee Lau
This map shows the geographic impact of Wan Yee Lau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wan Yee Lau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wan Yee Lau more than expected).
Fields of papers citing papers by Wan Yee Lau
This network shows the impact of papers produced by Wan Yee Lau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wan Yee Lau. The network helps show where Wan Yee Lau may publish in the future.
Co-authorship network of co-authors of Wan Yee Lau
This figure shows the co-authorship network connecting the top 25 collaborators of Wan Yee Lau. A scholar is included among the top collaborators of Wan Yee Lau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wan Yee Lau. Wan Yee Lau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 8 | |
| 3 | 3 | |
| 4 | 18 | |
| 5 | TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching studybreakdown → | 71 |
| 6 | 5 | |
| 7 | 23 | |
| 8 | 1 | |
| 9 | 48 | |
| 10 | 35 | |
| 11 | 0 | |
| 12 | 4 | |
| 13 | 89 | |
| 14 | Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trialbreakdown → | 369 |
| 15 | 26 | |
| 16 | 2 | |
| 17 | 467 | |
| 18 | THE BRISBANE 2000 TERMINOLOGY OF LIVER ANATOMY AND RESECTION | 51 |
| 19 | Case 18. Presentation | 1 |
| 20 | 11 |
About Wan Yee Lau
Wan Yee Lau is a scholar working on Hepatology, Surgery and Oncology, having authored 440 papers that have together received 19.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (254 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (141 papers) and Liver Disease Diagnosis and Treatment (118 papers). The work is most often cited by research in Hepatology (10.8k citations), Oncology (5.4k citations) and Surgery (8.0k citations). Wan Yee Lau has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Eric C. H. Lai, Paul B.S. Lai, Rong Guo, Min-Shan Chen, Mengchao Wu, Ya-Qi Zhang, Xiao-Jun Lin, Ka Lau Leung, Jin-Qing Li and Simon C.H. Yu. Their work appears in journals such as The Lancet, Nature Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.